Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HKMPFOTCMKTS:NRILYOTCMKTS:SMCAYOTCMKTS:SZKMY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHKMPFHikma Pharmaceuticals$27.73$26.88$22.56▼$28.92$6.15B0.571,600 shsN/ANRILYNomura Research Institute$40.46+1.0%$38.68$26.47▼$42.57$23.52B0.6358,075 shs34,104 shsSMCAYSMC$18.63-0.6%$17.25$14.30▼$26.56$23.95B1.03564,718 shs454,671 shsSZKMYSuzuki Motor$46.980.0%$47.68$37.73▼$53.83$23.08B0.6356,154 shs18,044 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHKMPFHikma Pharmaceuticals0.00%0.00%+2.97%+7.47%+9.82%NRILYNomura Research Institute+0.97%+1.53%-0.81%+19.95%+51.88%SMCAYSMC-0.64%-1.14%+8.38%-2.92%-25.84%SZKMYSuzuki Motor-0.04%+1.51%-8.12%-2.63%-3.53%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHKMPFHikma PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ANRILYNomura Research Institute2.8472 of 5 stars0.05.01.70.02.91.71.3SMCAYSMC1.5997 of 5 stars0.03.01.70.02.20.01.9SZKMYSuzuki Motor2.4755 of 5 stars0.05.01.70.01.10.02.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHKMPFHikma Pharmaceuticals 3.50Strong BuyN/AN/ANRILYNomura Research Institute 2.00HoldN/AN/ASMCAYSMC 0.00N/AN/AN/ASZKMYSuzuki Motor 4.00Strong BuyN/AN/ACurrent Analyst Ratings BreakdownLatest HKMPF, SMCAY, SZKMY, and NRILY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025HKMPFHikma PharmaceuticalsBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform4/14/2025SZKMYSuzuki MotorSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHKMPFHikma Pharmaceuticals$2.88B2.14$3.28 per share8.46$10.03 per share2.76NRILYNomura Research Institute$5.10B4.61$1.79 per share22.64$4.84 per share8.36SMCAYSMC$5.38B4.42$1.14 per share16.39$9.96 per share1.87SZKMYSuzuki Motor$37.23B0.62$5.91 per share7.95$49.73 per share0.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHKMPFHikma Pharmaceuticals$190MN/A0.00∞N/AN/AN/AN/A8/7/2025 (Estimated)NRILYNomura Research Institute$549.54M$1.0838.5336.13N/A11.96%21.78%9.99%7/24/2025 (Estimated)SMCAYSMC$1.23B$0.8022.7222.1816.7320.52%8.31%7.52%8/8/2025 (Estimated)SZKMYSuzuki Motor$1.85B$5.668.308.73N/AN/AN/AN/A8/5/2025 (Estimated)Latest HKMPF, SMCAY, SZKMY, and NRILY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q4 2025SMCAYSMC$0.14$0.19+$0.05$0.19$200.60 billion$1.32 billion5/12/2025Q4 2025SZKMYSuzuki Motor$1.24$1.42+$0.18$1.42$1,489.49 billion$10.11 billion4/24/2025Q4 2025NRILYNomura Research InstituteN/A$0.25N/A$0.25$1.42 billion$1.29 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHKMPFHikma Pharmaceuticals$0.963.46%N/AN/AN/ANRILYNomura Research Institute$0.310.77%N/A28.70%N/ASMCAYSMC$0.110.59%N/A13.75%N/ASZKMYSuzuki Motor$0.360.77%N/A6.36%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHKMPFHikma Pharmaceuticals0.461.660.98NRILYNomura Research Institute0.521.811.97SMCAYSMCN/A9.375.86SZKMYSuzuki Motor0.131.581.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHKMPFHikma PharmaceuticalsN/ANRILYNomura Research InstituteN/ASMCAYSMC1.03%SZKMYSuzuki Motor0.02%Insider OwnershipCompanyInsider OwnershipHKMPFHikma PharmaceuticalsN/ANRILYNomura Research Institute61.10%SMCAYSMCN/ASZKMYSuzuki MotorN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHKMPFHikma Pharmaceuticals9,100221.89 millionN/ANot OptionableNRILYNomura Research Institute6,782581.24 million226.10 millionNot OptionableSMCAYSMC23,1711.28 billionN/ANot OptionableSZKMYSuzuki Motor72,372491.15 millionN/ANot OptionableHKMPF, SMCAY, SZKMY, and NRILY HeadlinesRecent News About These CompaniesMaruti Suzuki Gets NCLT Nod to Merge Suzuki Motor GujaratJune 12 at 3:59 AM | indiainfoline.comExclusive: India's Maruti Suzuki cuts near-term EV production amid rare earths crisisJune 10 at 5:47 AM | reuters.comSuzuki Motor halted Swift car production due to China's rare earth curb, Nikkei saysJune 6, 2025 | economictimes.indiatimes.comSuzuki Motor Halts Swift Production Amid China's Rare Earth Curb: SourcesJune 6, 2025 | msn.comSuzuki Motor halted Swift production due to China's rare earth curbs - reportJune 6, 2025 | msn.comShould Value Investors Buy Suzuki Motor (SZKMY) Stock?June 5, 2025 | zacks.comSuzuki Motor halted Swift car production due to China’s rare earth curb, Nikkei saysJune 5, 2025 | brecorder.comSuzuki Motor halted Swift production due to China's rare earth curb, sources sayJune 5, 2025 | reuters.comSuzuki Motor (OTCMKTS:SZKMY) Trading 0.9% Higher - What's Next?June 4, 2025 | marketbeat.comSuzuki Motor Co. (OTCMKTS:SZKMY) Sees Significant Decline in Short InterestJune 1, 2025 | marketbeat.comSuzuki Motorcycle India to set up ₹1,200 crore plant in Haryana’s KharkhodaMay 20, 2025 | fortuneindia.comSuzuki Motor’s boil-in-the-bag curry for Indian employees to hit store shelvesMay 17, 2025 | thestar.com.mySuzuki Motor (OTCMKTS:SZKMY) Releases FY 2025 Earnings GuidanceMay 14, 2025 | marketbeat.comSuzuki Motor (OTCMKTS:SZKMY) Posts Earnings Results, Beats Estimates By $0.18 EPSMay 14, 2025 | marketbeat.comPassenger car market to rise 1-2% in FY26: Suzuki Motor CorporationMay 13, 2025 | telegraphindia.comSuzuki Motor expects to grow 1-2% in India in FY26May 12, 2025 | thehindubusinessline.comFormer Suzuki Motor Chief, Osamu Suzuki, Posthumously Conferred with Padma VibhushanApril 29, 2025 | ndtv.comFormer Suzuki Motor Chairman Osamu Suzuki conferred with Padma Vibhushan posthumouslyApril 29, 2025 | auto.economictimes.indiatimes.comEx-Suzuki Motor chief Osamu Suzuki, singer Pankaj Udhas, Sushil Modi among Padma awardeesApril 28, 2025 | thehindu.comOsamu Suzuki, former CEO of Suzuki Motor, posthumously conferred with Padma VibhushanApril 28, 2025 | theprint.inSuzuki Motor Corp, Maruti Suzuki to set up Osamu Suzuki Centre in IndiaApril 23, 2025 | business-standard.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHKMPF, SMCAY, SZKMY, and NRILY Company DescriptionsHikma Pharmaceuticals OTCMKTS:HKMPF$27.73 0.00 (0.00%) As of 06/12/2025Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.Nomura Research Institute OTCMKTS:NRILY$40.46 +0.39 (+0.97%) As of 06/12/2025 03:59 PM EasternNomura Research Institute, Ltd. provides consulting, financial information technology (IT) solution, industrial IT solution, and IT platform services in Japan and internationally. Its Consulting segment offers management, operational, and system consulting services for enterprises and government agencies. This segment also offers research, future projections, and recommendations to society, economics, business, technology, etc. The company's Financial IT Solutions segment provides system consulting, development, and management solutions, as well as shared online and BPO services for the financial institutions, including the securities, insurance, banking, asset management, and other financial sectors. Its Industrial IT Solutions segment offers system consulting, development, and management solutions, as well as shared online services primarily for the distribution, manufacturing, service, and public sectors. The company's IT Platform Services segment engages in the data center operation activities and construction of IT platforms and networks to the Financial IT and Industrial IT Solutions segments, as well as provides IT platform solutions and information security services to external clients. This segment is also involved in the research related to advance IT, etc. The company was founded in 1965 and is headquartered in Tokyo, Japan.SMC OTCMKTS:SMCAY$18.63 -0.12 (-0.64%) As of 06/12/2025 03:59 PM EasternSMC Corporation manufactures, processes, and sells automatic control equipment, sintered filters, and various types of filtration equipment worldwide. The company offers air management system, directional control valves, air cylinders, rotatory actuators/air grippers, electric actuators/cylinders, fitting and tubing, and modular F.R.L./pressure control equipment, as well as vacuum, air preparation, and lubrication equipment. It also provides flow control equipment, speed controllers, silencers/exhaust/blow guns/pressure gauges, switches/sensors/controllers, static neutralization equipment, and industrial device communication equipment/wireless system. In addition, the company offers process valves, chemical liquid valves/fittings and needle valves/tubing, process pumps, temperature control equipment, and process gas equipment, as well as high vacuum equipment, industrial filters/sintered metal elements, and pneumatic instrumentation and hydraulic equipment. The company was formerly known as Shoketsu Kinzoku Kogyo Co., Ltd. and changed its name to SMC Corporation in April 1986. SMC Corporation was incorporated in 1959 and is headquartered in Tokyo, Japan.Suzuki Motor OTCMKTS:SZKMY$46.98 -0.02 (-0.04%) As of 06/12/2025 03:58 PM EasternSuzuki Motor Corporation engages in the manufacturing and marketing of automobiles, motorcycles, and marine products in Japan, rest of Asia, Europe, North America, and internationally. It offers mini-vehicles, sub-compact vehicles, standard-sized vehicles, outboard motors, motorized wheelchairs, and electro senior vehicles. The company is also involved in solar power generation and logistics business, as well as provides other services. Suzuki Motor Corporation was founded in 1909 and is headquartered in Hamamatsu, Japan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
